CervoMed
CervoMed is a clinical-stage biotechnology company focused on developing treatments for age-related neurologic disorders. Its lead product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction in diseases like Dementia with Lewy Bodies (DLB) and other related neurological conditions.
Top Sectors
Top Stages
1 past transactions
EIP Pharma
Acquisition in 2023
EIP Pharma, LLC is a clinical-stage therapeutics company based in Cambridge, Massachusetts, that specializes in researching and developing solutions for central nervous system (CNS) disorders. Incorporated in 2010, the company focuses on the development and commercialization of drug treatments aimed at neurodegenerative diseases, particularly those affecting the early stages of the neurodegenerative process. EIP Pharma's innovative drug candidates are designed to promote functional recovery in patients experiencing acute neurologic injuries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.